Starten Sie Ihre Suche...

Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen

SFB 432: Mechanismen der Tumorabwehr und ihre therapeutische Beeinflussung

Forschungsverbund / Johannes Gutenberg-Universität Mainz

Ergebnisse pro Seite:  100

Erlach, KC; Bohm, V; Knabe, M et al.

Activation of hepatic natural killer cells and control of liver-adapted lymphoma in the murine model of cytomegalovirus infection.

Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 167-78

Holtappels, R; Bohm, V; Podlech, J et al.

CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.

Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 125-34

Sahin, U; Koslowski, M; Dhaene, K et al.

Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development.

Clin Cancer Res. Bd. 14. H. 23. 2008 S. 7624-34

Wolfel, C; Lennerz, V; Lindemann, E et al.

Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation.

Cancer Immunol Immunother. Bd. 57. H. 6. 2008 S. 849-57

Cicin-Sain, L; Ruzsics, Z; Podlech, J et al.

Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene.

J Virol. Bd. 82. H. 5. 2008 S. 2056-64

Bohm, V; Podlech, J; Thomas, D et al.

Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.

Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 135-44

Tschiedel, S; Gentilini, C; Lange, T et al.

Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia.

Leukemia. Bd. 22. H. 8. 2008 S. 1542-50

Javorovic, M; Wilde, S; Zobywalski, A et al.

Inhibitory effect of RNA pool complexity on stimulatory capacity of RNA-pulsed dendritic cells.

J Immunother. Bd. 31. H. 1. 2008 S. 52-62

Holtappels, R; Simon, CO; Munks, MW et al.

Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.

J Virol. Bd. 82. H. 12. 2008 S. 5781-96

Hahnel, PS; Thaler, S; Antunes, E et al.

Targeting AKT signaling sensitizes cancer to cellular immunotherapy.

Cancer Res. Bd. 68. H. 10. 2008 S. 3899-906

Koslowski, M; Sahin, U; Mitnacht-Kraus, R et al.

A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes.

Cancer Res. Bd. 67. H. 19. 2007 S. 9528-34

Roos, WP; Batista, LFZ; Naumann, S et al.

Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine

Oncogene. Bd. 26. 2007 S. 186-197

Kuball, J; Dossett, ML; Wolfl, M et al.

Facilitating matched pairing and expression of TCR chains introduced into human T cells.

Blood. Bd. 109. H. 6. 2007 S. 2331-8

Tuettenberg, A; Koelsch, S; Knop, J et al.

Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cells.

Exp Dermatol. Bd. 16. 2007 S. 171-178

Besold, K; Frankenberg, N; Pepperl-Klindworth, S et al.

Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion

J Gen Virol. Bd. 88. 2007 S. 1429-1439

Meyer, RG; Britten, CM; Wehler, D et al.

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation.

Blood. Bd. 109. H. 1. 2007 S. 374-82

Meyer, RG; Graf, C; Britten, CM et al.

Rapid identification of an HLA-B*1501-restricted vaccinia peptide antigen.

Vaccine. Bd. 25. H. 24. 2007 S. 4715-22

Kreiter, S; Konrad, T; Sester, M et al.

Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA.

Cancer Immunol Immunother. Bd. 56. H. 10. 2007 S. 1577-87

Blank, C; Kuball, J; Voelkl, S et al.

Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.

Int J Cancer. Bd. 119. H. 2. 2006 S. 317-27

Christmann, M; Tomicic, MT; Origer, D et al.

c-Fos is required for excision repair of UV-light induced DNA lesions by triggering the resynthesis of XPF

Nucleic Acids Res. Bd. 34. 2006 S. 6530-6539

Simon, CO; Holtappels, R; Tervo, HM et al.

CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.

J Virol. Bd. 80. H. 21. 2006 S. 10436-56

Holtappels, R; Munks, MW; Podlech, J et al.

CD8 T-cell-based immunotherapy of cytomegalovirus disease in the mouse model of the immunocompromised bone marrow transplantation recipient

M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. 1. Aufl. Wymondham, Norfolk, United Kingdom: Caister Academic Press 2006

Kiesslich, R; Hoffman, A; Neurath, MF

Colonoscopy, tumors, and inflammatory bowel disease - new diagnostic methods.

Endoscopy. Bd. 38. H. 1. 2006 S. 5-10

Holtappels, R; Gillert-Marien, D; Thomas, D et al.

Cytomegalovirus encodes a positive regulator of antigen presentation.

J Virol. Bd. 80. H. 15. 2006 S. 7613-24

Hartwig, UF; Nonn, M; Khan, S et al.

Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes.

Bone Marrow Transpl. Bd. 37. H. 3. 2006 S. 297-305

Roos, WP; Kaina, B

DNA damage-induced cell death by apoptosis

Trends in Molecular Medicine. Bd. 12. H. 9. 2006 S. 440-450

Steitz, J; Britten, CM; Wolfel, T et al.

Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2.

Cancer Immunol Immunother. Bd. 55. H. 3. 2006 S. 246-53

Kuphal, S; Wallner, S; Schimanski, CC et al.

Expression of Hugl-1 is strongly reduced in malignant melanoma.

Oncogene. Bd. 25. H. 1. 2006 S. 103-10

Grunwald, C; Koslowski, M; Arsiray, T et al.

Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer.

Int J Cancer. Bd. 118. H. 10. 2006 S. 2522-8

Klamp, T; Sahin, U; Kyewski, B et al.

Expression profiling of autoimmune regulator AIRE mRNA in a comprehensive set of human normal and neoplastic tissues.

Immunol Lett. Bd. 106. H. 2. 2006 S. 172-9

Tureci, O; Mack, U; Luxemburger, U et al.

Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1.

Cancer Lett. Bd. 236. H. 1. 2006 S. 64-71

Wu, J; Helftenbein, G; Koslowski, M et al.

Identification of new claudin family members by a novel PSI-BLAST based approach with enhanced specificity.

Proteins. Bd. 65. H. 4. 2006 S. 808-15

Erlach, KC; Böhm, V; Seckert, CK et al.

Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection.

J Virol. Bd. 80. H. 10. 2006 S. 4801-19

Su, Z; Kuball, J; Barreiros, AP et al.

Nitric oxide promotes resistance to tumor suppression by CTLs.

J Immunol. Bd. 176. H. 7. 2006 S. 3923-30

Chromik, J; Schnurer, E; Meyer, RG et al.

Proteasome-inhibited dendritic cells demonstrate improved presentation of exogenous synthetic and natural HLA-class I peptide epitopes.

J Immunol Methods. Bd. 308. H. 1-2. 2006 S. 77-89

Sahin, U; Tureci, O; Graf, C et al.

Rapid molecular dissection of viral and bacterial immunomes.

Eur J Immunol. Bd. 36. H. 4. 2006 S. 1049-57

Wehler, T; Wolfert, F; Schimanski, CC et al.

Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease.

Oncol Rep. Bd. 16. H. 6. 2006 S. 1159-64

Kausche, S; Wehler, T; Schnürer, E et al.

Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.

Cancer Res. Bd. 66. H. 23. 2006 S. 11447-11454

Koslowski, M; Sahin, U; Huber, C et al.

The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexes.

Hum Mol Genet. Bd. 15. H. 15. 2006 S. 2392-9